A Phase 1 Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of ABT-263 (Navitoclax).

Trial Profile

A Phase 1 Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of ABT-263 (Navitoclax).

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Apr 2014

At a glance

  • Drugs Ketoconazole (Primary) ; Navitoclax (Primary)
  • Indications Cancer; Haematological malignancies
  • Focus Pharmacokinetics
  • Sponsors AbbVie
  • Most Recent Events

    • 17 Dec 2010 Actual end date (Oct 2010) added as reported by ClinicalTrials.gov.
    • 17 Dec 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 14 Oct 2010 Actual initiation date changed from Dec 2009 to Jan 2010 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top